Bramacare launches AI platform to streamline eating disorder care
Bramacare has released AMY, an AI-enabled platform designed for eating disorder and rehabilitation services. The system integrates physical health monitoring, risk assessment, care planning and compliance tracking into a single patient record-the first of its kind in the UK.
A clinical design team with specialist eating disorder experience built AMY around the Medical Emergencies in Eating Disorders (MEED) guidelines. The platform automates decision-making processes that were previously manual and fragmented across multiple services.
How it works
AMY continuously monitors risk across multiple domains: suicide and self-harm, falls, ligature risk and medication concerns. Risk profiles update automatically as new clinical information enters the system.
The platform time-stamps all alerts and tracks them to resolution, automatically generating audit trails for every patient interaction. This creates an evidence base for clinical governance rather than relying on procedural checks alone.
Alerts route to senior clinicians, GPs, consultants, acute services or safeguarding leads through configurable escalation pathways. Real-time dashboards show service-level risk and performance to managers and safeguarding leads.
Additional modules cover dietetic planning, medication management, psychological intervention, occupational therapy and individualised risk assessments.
The demand context
At least 1.25 million people in the UK live with an eating disorder. The number of children and young people starting treatment reached 11,174 in 2024/25-an increase of nearly 40% since the pandemic.
Dr Ramoo, Clinical Lead and Co-Founder of Bramacare, said: "Specialist eating disorder care is one of the most clinically complex areas of medicine. AMY was developed to provide clinical teams with a more effective way to make faster, safer, and more consistent decisions, while reducing the admin burden they already carry."
Next steps
The platform is currently in structured clinical evaluation. First pilots begin in 2026 with NHS trust partners.
Your membership also unlocks:
